Jason R. Buck

1.0k total citations
24 papers, 854 citations indexed

About

Jason R. Buck is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Genetics. According to data from OpenAlex, Jason R. Buck has authored 24 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Jason R. Buck's work include Radiopharmaceutical Chemistry and Applications (9 papers), Glioma Diagnosis and Treatment (7 papers) and Medical Imaging Techniques and Applications (6 papers). Jason R. Buck is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (9 papers), Glioma Diagnosis and Treatment (7 papers) and Medical Imaging Techniques and Applications (6 papers). Jason R. Buck collaborates with scholars based in United States, Australia and Russia. Jason R. Buck's co-authors include H. Charles Manning, Dewei Tang, H. Alex Brown, Michelle D. Armstrong, Craig W. Lindsley, Sarah Scott, Michael L. Nickels, Carlos L. Arteaga, Matthew R. Hight and Hyekyung P. Cho and has published in prestigious journals such as PLoS ONE, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Jason R. Buck

24 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jason R. Buck United States	16	445	193	192	144	107	24	854
Rob Ruijtenbeek Netherlands	21	854 1.9×	219 1.1×	206 1.1×	90 0.6×	215 2.0×	64	1.2k
Astrid Katzer Germany	20	552 1.2×	134 0.7×	87 0.5×	343 2.4×	62 0.6×	28	891
Birgitte Brinkmann Olsen Denmark	20	691 1.6×	291 1.5×	187 1.0×	95 0.7×	35 0.3×	53	1.1k
Melanie Wong United States	17	418 0.9×	156 0.8×	54 0.3×	115 0.8×	160 1.5×	23	830
Jangsoon Lee United States	18	684 1.5×	434 2.2×	187 1.0×	166 1.2×	50 0.5×	40	1.1k
Sara Pignatta Italy	15	332 0.7×	313 1.6×	65 0.3×	98 0.7×	45 0.4×	26	816
Michael L. Nickels United States	16	526 1.2×	280 1.5×	219 1.1×	369 2.6×	56 0.5×	36	1.2k
Ian Lewis Switzerland	17	566 1.3×	397 2.1×	176 0.9×	37 0.3×	144 1.3×	26	1.9k
Teresa Riccioni Italy	18	545 1.2×	143 0.7×	66 0.3×	104 0.7×	185 1.7×	25	893
Ryuichi Ohgaki Japan	22	798 1.8×	209 1.1×	222 1.2×	106 0.7×	20 0.2×	45	1.4k

Countries citing papers authored by Jason R. Buck

Since Specialization

Citations

This map shows the geographic impact of Jason R. Buck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason R. Buck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason R. Buck more than expected).

Fields of papers citing papers by Jason R. Buck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason R. Buck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason R. Buck. The network helps show where Jason R. Buck may publish in the future.

Co-authorship network of co-authors of Jason R. Buck

This figure shows the co-authorship network connecting the top 25 collaborators of Jason R. Buck. A scholar is included among the top collaborators of Jason R. Buck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason R. Buck. Jason R. Buck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Buck, Jason R., Samir Saleh, Christine M. Lovly, et al.. (2020). N-[18F]-Fluoroacetylcrizotinib: A potentially potent and selective PET tracer for molecular imaging of non-small cell lung cancer. Bioorganic & Medicinal Chemistry Letters. 30(16). 127257–127257. 4 indexed citations

Tang, Dewei, Jason R. Buck, Yan Xia, et al.. (2016). Evaluation of TSPO PET Ligands [18F]VUIIS1009A and [18F]VUIIS1009B: Tracers for Cancer Imaging. Molecular Imaging and Biology. 19(4). 578–588. 16 indexed citations

Osgood, Christy, Mohammed Noor Tantawy, Zachary Madaj, et al.. (2016). 18F-FLT Positron Emission Tomography (PET) is a Pharmacodynamic Marker for EWS-FLI1 Activity and Ewing Sarcoma. Scientific Reports. 6(1). 33926–33926. 10 indexed citations

Manning, H. Charles, Jason R. Buck, & Rebecca S. Cook. (2016). Mouse Models of Breast Cancer: Platforms for Discovering Precision Imaging Diagnostics and Future Cancer Medicine. Journal of Nuclear Medicine. 57(Supplement 1). 60S–68S. 32 indexed citations

Buck, Jason R., Eliot T. McKinley, Allie Fu, et al.. (2015). Preclinical TSPO Ligand PET to Visualize Human Glioma Xenotransplants: A Preliminary Study. PLoS ONE. 10(10). e0141659–e0141659. 19 indexed citations

Hassanein, Mohamed, Matthew R. Hight, Jason R. Buck, et al.. (2015). Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung Cancer. Molecular Imaging and Biology. 18(1). 18–23. 39 indexed citations

Hight, Matthew R., Yiu‐Yin Cheung, Michael L. Nickels, et al.. (2014). A Peptide-Based Positron Emission Tomography Probe for In Vivo Detection of Caspase Activity in Apoptotic Cells. Clinical Cancer Research. 20(8). 2126–2135. 26 indexed citations

Tang, Dewei, Michael L. Nickels, Mohammed Noor Tantawy, Jason R. Buck, & H. Charles Manning. (2014). Preclinical Imaging Evaluation of Novel TSPO-PET Ligand 2-(5,7-Diethyl-2-(4-(2-[18F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide ([18F]VUIIS1008) in Glioma. Molecular Imaging and Biology. 16(6). 813–820. 33 indexed citations

Nickels, Michael L., et al.. (2014). High-yielding, automated production of 3′-deoxy-3′-[ 18 F]fluorothymidine using a modified Bioscan Coincidence FDG reaction module. Applied Radiation and Isotopes. 97. 47–51. 9 indexed citations

10.

Nickels, Michael L., et al.. (2014). Facile synthesis of SSR180575 and discovery of 7-chloro-N,N,5-trimethyl-4-oxo-3(6-[18F]fluoropyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide, a potent pyridazinoindole ligand for PET imaging of TSPO in cancer. Bioorganic & Medicinal Chemistry Letters. 24(18). 4466–4471. 23 indexed citations

11.

Uddin, Md. Imam, Jason R. Buck, M. Schulte, et al.. (2013). Microwave-assisted, one-pot reaction of 7-azaindoles and aldehydes: a facile route to novel di-7-azaindolylmethanes. Tetrahedron Letters. 55(1). 169–173. 10 indexed citations

12.

Tang, Dewei, Matthew R. Hight, Eliot T. McKinley, et al.. (2012). Quantitative Preclinical Imaging of TSPO Expression in Glioma Using N,N-Diethyl-2-(2-(4-(2-¹⁸F-Fluoroethoxy)Phenyl)-5,7-Dimethylpyrazolo[1,5-a]Pyrimidin-3-yl)Acetamide. Journal of Nuclear Medicine. 53(2). 287–294. 55 indexed citations

13.

Buck, Jason R., et al.. (2012). Rapid, microwave-assisted organic synthesis of selective V600EBRAF inhibitors for preclinical cancer research. Tetrahedron Letters. 53(32). 4161–4165. 17 indexed citations

14.

Buck, Jason R., Eliot T. McKinley, Matthew R. Hight, et al.. (2010). Quantitative, Preclinical PET of Translocator Protein Expression in Glioma Using ¹⁸F-N-Fluoroacetyl-N-(2,5-Dimethoxybenzyl)-2-Phenoxyaniline. Journal of Nuclear Medicine. 52(1). 107–114. 51 indexed citations

15.

Tang, Dewei, Jason R. Buck, Matthew R. Hight, & H. Charles Manning. (2010). Microwave-assisted organic synthesis of a high-affinity pyrazolo-pyrimidinyl TSPO ligand. Tetrahedron Letters. 51(35). 4595–4598. 13 indexed citations

16.

Buck, Jason R., Eliot T. McKinley, Matthew R. Hight, et al.. (2010). Preclinical evaluation of TSPO ligand [18F]PBR06 for PET imaging of glioma. 51. 279–279. 1 indexed citations

17.

Shah, Chirayu, Todd W. Miller, Shelby K. Wyatt, et al.. (2009). Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer. Clinical Cancer Research. 15(14). 4712–4721. 69 indexed citations

18.

Lewis, Jana A., Sarah Scott, Robert R. Lavieri, et al.. (2009). Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificity. Bioorganic & Medicinal Chemistry Letters. 19(7). 1916–1920. 84 indexed citations

19.

Scott, Sarah, Jason R. Buck, Hyekyung P. Cho, et al.. (2009). Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nature Chemical Biology. 5(2). 108–117. 234 indexed citations

20.

Wang, Zhiwei, et al.. (2000). Stereocontrolled Syntheses of Deoxyribonucleosides via Photoinduced Electron-Transfer Deoxygenation of Benzoyl-Protected Ribo- and Arabinonucleosides. The Journal of Organic Chemistry. 65(19). 5969–5985. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact